MarketInOut Stock Screener Log In | Sign Up

Nectar Lifesciences Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:58
Nectar Lifesciences Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization1,997 mln
Float89.44 mln

EPS

0.35
Marginal

P / E

29.54
Elevated

Piotroski F-Score

4 / 9
Borderline

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.79
Moderate leverage

Pre-Tax Margin

-342%
Severely loss-making

Business Description

Nectar Lifesciences Limited is an Indian pharmaceutical company founded in 1995 and based in Chandigarh, with operations spanning both domestic and international markets. The company specializes in producing a broad range of cephalosporin-based antibiotics, including active ingredients, intermediates, and finished medicines in forms such as tablets, capsules, suspensions, and injectables. It also takes on manufacturing work for other pharmaceutical companies and produces menthol and pearl capsules.

Key Fundamentals

EPS0.35
P/E29.54
ROE-32.60
RPS0.00
ROA-16.40
Interest Cover-2.40
EBITDA, mln113
EV / EBITDA7.90
EV / EBIT8.24
Revenue, mln74.43
EV / Revenue11.98

Quote Details

Last 10.34
Change -0.19 (-1.8%)
Open 10.58
Volume 129,856
Turnover 1,342,711
Average Volume 173,475

Financial Ratios

Pre-Tax Profit Margin-342
Current Ratio9.71
Price / Book0.35
Price / Tangible Book0.35
Price / Cash Flow1.31
Price / Free Cash Flow1.39
Debt / Equity0.79
Price / Sales30.71

Financial Strength

Altman Z-Score4.35
Piotroski F-Score 4 / 9
Price to Intrinsic Value1.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.41% 9 / 100   
1 Month -4.61% 65 / 100   
2 Months -3.36% 64 / 100   
6 Months -17.68% 30 / 100   
1 Year -23.24% 39 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog